Govind Babu K - Kidwai Memorial Institute of Oncology

基本信息

浏览量：30

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 225 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women with Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer

JOURNAL OF CLINICAL ONCOLOGYno. 23 (2024)

引用0浏览0WOS引用

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Vs Combination Chemotherapy in Premenopausal Women with Clinically Aggressive HR+/HER2− Advanced Breast Cancer

Yen-Shen Lu, Enzal Izwadi Bin Mohd Mahidin, Hamdy Azim,Yesim Eralp,Yoon Sim Yap,Seock-Ah Im,Julie Rihani,Erhan Gokmen,Ahmed El Bastawisy,Nuri Karadurmus, Yeuh Ni Lim,Chun Sen Lim,Le Thanh Duc,Wei-Pang Chung,K. Govind Babu,Konstantin Penkov,James Bowles,Teresa Delgar Alfaro,Jiwen Wu,Melissa Gao,Khemaies Slimane,Nagi S. El Saghir

Journal of Clinical Oncology (2024)

引用0浏览0引用

Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients

Prerana Jha,Asim Joshi,Rohit Mishra, Ranendra Pratap Biswal,Pooja Mahesh Kulkarni,Sewanti Limaye,Govind Babu,Ullas Batra,Prabhat Malik, Rajiv Kumar,Minit Shah,Nandini Menon,Amit Rauthan,Moni Kuriakose,Venkataramanan Ramachandran,Vanita Noronha,Prashant Kumar,Kumar Prabhash

Clinical Lung Cancer (2024)

引用0浏览0WOS引用

Consensus Guidelines for the Management of HR-positive HER2/neu Negative Early Breast Cancer in India, SAARC Region and Other LMIC by DELPHI Survey Method

Purvish Parikh,Govind Babu,Randeep Singh,Vamshi Krishna,Amit Bhatt,Indu Bansal,Senthil Rajappa,Tarini Prasad Sahoo,Shyam Aggarwal,Ajay Bapna,Ghanshyam Biswas,SP Somashekhar,Jyoti Bajpai, Vashishtha Maniar,Sharad Desai,T Raja,Goura Kishor Rath

BMC Cancer（2023）

引用0浏览0WOS引用

Ten Years Survival Results of Randomized Study Comparing Weekly Vs. Triweekly Cisplatin with Concurrent Radiation in Locally Advanced Carcinoma Cervix

R. Nanda,Aradhana Katke,B. Thejaswini,G. Giri,Yashwant Pawar,M. Manjula,Govind Babu

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPYno. 3 (2023): 322-331

引用0浏览0WOS引用

Efficacy and Safety of Ceritinib 450 Mg/day with Food and 750 Mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis

Byoung Chul Cho,Dong-Wan Kim,Ullas Batra,Keunchil Park,Sang -We Kim,Cheng-Ta Yang,Pei-Jye Voon,Virote Sriuranpong,K. Govind Babu, Khalid Amin,Yingbo Wang,Paramita Sen,Khemaies Slimane,Sarayut Geater

Cancer Research and Treatment（2023）

引用0浏览0WOS引用

Optical Genome Mapping for Genome-Wide Structural Variation Analysis in Hematologic Malignancies: A Prospective Study Demonstrates Additional Findings Compared to Standard-of-Care (SOC) Cytogenomic Methods

Stephen J. Wicks, Marissa Younan,Trilochan Sahoo,Jen Hauenstein,Anusha Mylavarapu,Beth Matthews,Karine Hovanes, Meena Naik,Nishit Ojha,Amey Panchal, Yesheswini Naik, Rahul Arora, Vishwadeep Khushoo, Vasu Babu, Nishad Dhakate, Poonam Jain,Punit Jain,Govind Babu,Sandeep Rao,Sachin Jadhav

Bloodno. Supplement 1 (2023): 2834-2834

引用0浏览0引用

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer

S. Koppikar,A. Oaknin,K. Govind Babu,D. Lorusso,S. Gupta,L. -Y. Wu,W. Rajabto,K. Harano, S. -h. Hong, R. A. Malik, H. Strebel, I. M. Aggarwal, C. -H. Lai,T. Dejthevaporn,S. Tangjitgamol, W. F. Cheng,W. Y. Chay, D. Benavides, N. M. Hashim, Y. W. Moon,M. Yunokawa,T. D. Anggraeni, W. Wei,G. Curigliano,A. Maheshwari,U. Mahantshetty, S. Sheshadri,S. Peters,T. Yoshino,G. Pentheroudakis

ESMO OPEN（2023）

引用4浏览0WOS引用

ChatGPT—Preliminary Overview with Implications for Medicine and Oncology

Purvish M. Parikh, Dinesh Shah, Urvish Parikh,Ajit Venniyoor,Govind Babu, Akhil Ranjan Garg,Hemant Malhotra

Indian journal of medical and paediatric oncologyno. 04 (2023): 377-383

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn